Teva Announces Proposed Acquisition Of A Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot To Growth Strategy

(MENAFN - GlobeNewsWire - Nasdaq) BXCL501, a novel dexmedetomidine sublingual film, is under FDA review for potential at-home (outpatient) use for the acute treatment of agitation associated with ...